Medicapedia ESENCA
Image of Cystic fibrosis
Image: Wikimedia Commons

Cystic fibrosis

1938 · inherited genetic disorder affecting mainly the lungs and pancreas

Share:FacebookWhatsApp

Before its cause was understood, cystic fibrosis puzzled physicians. Affected children often grew poorly, passed bulky, greasy stools and suffered repeated chest infections. Because the condition was not seen as a single disease, cases were attributed to digestive ailments, tuberculosis or other illnesses, and the outlook was bleak. Treatment was largely supportive: diet, close observation and antibiotics when available.

The first clues appeared before the disease had a name. Carl von Rokitansky described a case of fetal death with meconium peritonitis, a complication of meconium ileus, an intestinal blockage in the newborn caused by meconium, the baby's first stool. Karl Landsteiner described meconium ileus in 1905, and both observations were later linked to cystic fibrosis. Still, no overall picture existed.

That step was taken by Dorothy Andersen. In 1938 she published in the American Journal of Diseases of Children a clinical and pathological study titled Cystic fibrosis of the pancreas and its relation to celiac disease. Andersen, an American pediatrician, gathered cases and showed that lung, pancreatic and intestinal disorders belonged to one illness, then called cystic fibrosis of the pancreas. She also proposed that it was recessive, meaning a child had to inherit an altered copy of the gene from each parent, and she used pancreatic enzyme replacement to help affected children digest fat. Acceptance was slow: many doctors found it hard to believe that several organs could be affected at once, and enzyme treatment eased symptoms without offering a cure.

Progress afterwards was gradual. In 1952 Paul di Sant' Agnese described abnormalities in the electrolytes of sweat, paving the way for the sweat test, which was developed and refined over the following decade. The major breakthrough came in 1985, when researchers in London, Toronto and Salt Lake City mapped the gene onto chromosome 7. In 1989 Francis Collins, Lap-Chee Tsui and John R. Riordan identified ΔF508, the most common mutation. Tsui led the team at the Hospital for Sick Children in Toronto that found the gene, and the discovery is regarded as the first genetic disorder elucidated strictly by reverse genetics, starting from the protein and the chromosome map rather than from the observed trait. Because CFTR mutations are usually small, classical methods could not pinpoint the gene; protein markers and chromosome walking and jumping were decisive.

More than a thousand distinct mutations are now known, and genotype helps predict how a patient's disease may evolve. There is still no cure, but most people with the condition now live far longer than in earlier decades, thanks to early diagnosis, respiratory physiotherapy, antibiotics and CFTR modulators, drugs that act on the specific defect. Cloning the gene also opened the door to gene therapy, which remains under investigation. The history of cystic fibrosis shows how a clinical description can precede its biological explanation by decades.

Key dates

  • 1905 Karl Landsteiner describes meconium ileus, an intestinal blockage in newborns.
  • 1938 Dorothy Andersen defines the disease as a distinct entity and proposes its recessive inheritance.
  • 1952 Paul di Sant' Agnese detects abnormalities in the electrolytes of sweat.
  • 1985 Researchers in London, Toronto and Salt Lake City map the gene on chromosome 7.
  • 1989 The most common mutation, ΔF508, is identified.

Key figures: Dorothy Andersen

Curiosities and anecdotes

A case before the name

Carl von Rokitansky described a fetal death with meconium peritonitis long before the disease had its own diagnosis. The link to cystic fibrosis came only later.

A salty taste

Parents sometimes noticed salt crystals on the skin of affected children, or a salty taste when kissing them. This is now known to be linked to the excess of salt in their sweat.

Two names for one disease

Besides cystic fibrosis, the term mucoviscidosis is also used, referring to the thick, sticky mucus that characterises the disease, while the first name describes the scarring and cysts that form in the pancreas.

Sources

Original Medicapedia text based on:

Last updated: 5 November 2026 · How Medicapedia is made

A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.